References(37)
[1]
Dobrovolskaia, M. A.; McNeil, S. E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2, 469-478.
[2]
Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; Mcneil, S. E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharmaceutics 2008, 5, 487-495.
[3]
Moghimi, S. M.; Simberg, D. Complement activation turnover on surfaces of nanoparticles. Nano Today 2017, 15, 8-10.
[4]
Ugurlar, D.; Howes, S. C.; de Kreuk, B. J.; Koning, R. I.; De Jong, R. N.; Beurskens, F. J.; Schuurman, J.; Koster, A. J.; Sharp, T. H. et al. Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement. Science 2018, 359, 794-797.
[5]
Galvan, M. D.; Greenlee-Wacker, M. C.; Bohlson, S. S. C1q and phagocytosis: The perfect complement to a good meal. J. Leukoc. Biol. 2012, 92, 489-497.
[6]
Schneider, S.; Zacharias, M. Atomic resolution model of the antibody Fc interaction with the complement C1q component. Mol. Immunol. 2012, 51, 66-72.
[7]
NayaK, A.; Pednekar, L.; Reid, K. B.; Kishore, U. Complement and non-complement activating functions of C1q: A prototypical innate immune molecule. Innate Immun. 2012, 18, 350-363.
[8]
Ricklin, D.; Hajishengallis, G.; Yang, K.; Lambris, J. D. Complement: A key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11, 785-797.
[9]
Sim, R. B.; Wallis, R. Immune attack on nanoparticles. Nat. Nanotechnol. 2011, 6, 80-81.
[10]
Gaboriaud, C.; Juanhuix, J.; Gruez, A.; Lacroix, M.; Darnault, C.; Pignol, D.; Verger, D.; Fontecilla-Camps, J. C.; Arlaud, G. J. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J. Biol. Chem. 2003, 278, 46974-46982.
[11]
Lee, C. H.; Romain, G.; Yan, W. P.; Watanabe, M.; Charab, W.; Todorova, B.; Lee, J.; Triplett, K.; Donkor, M.; Lungu, O. I. et al. IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions. Nat. Immunol. 2017, 18, 889-898.
[12]
Diebolder, C. A.; Beurskens, F. J.; de Jong, R. N.; Koning, R. I.; Strumane, K.; Lindorfer, M. A.; Voorhorst, M.; Ugurlar, D.; Rosati, S.; Heck, A. J. R. et al. Complement is activated by IgG hexamers assembled at the cell surface. Science 2014, 343, 1260-1263.
[13]
Gaboriaud, C.; Thielens, N. M.; Gregory, L. A.; Rossi, V.; Fontecilla-Camps, J. C.; Arlaud, G. J. Structure and activation of the C1 complex of complement: Unraveling the puzzle. Trends Immunol. 2004, 25, 368-373.
[14]
Gadjeva, M. G.; Rouseva, M. M.; Zlatarova, A. S.; Reid, K. B. M.; Kishore, U.; Kojouharova, M. S. Interaction of human C1q with IgG and IgM: Revisited. Biochemistry 2008, 47, 13093-13102.
[15]
Boraschi, D.; Italiani, P.; Palomba, R.; Decuzzi, P.; Duschl, A.; Fadeel, B.; Moghimi, S. M. Nanoparticles and innate immunity: New perspectives on host defence. Semin. Immunol. 2017, 34, 33-51.
[16]
Strasser, J.; de Jong, R. N.; Beurskens, F. J.; Schuurman, J.; Parren, P. W. H. I.; Hinterdorfer, P.; Preiner, J. Weak fragment crystallizable (Fc) domain interactions drive the dynamic assembly of IgG oligomers upon antigen recognition. ACS Nano 2020, 14, 2739-2750
[17]
Strasser, J.; de Jong, R. N.; Beurskens, F. J.; Wang, G. B.; Heck, A. J. R.; Schuurman, J.; Parren, P. W. H. I.; Hinterdorfer, P.; Preiner, J. Unraveling the macromolecular pathways of IgG oligomerization and complement activation on antigenic surfaces. Nano Lett. 2019, 19, 4787-4796.
[18]
Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, L.; Cedervall, T.; Dawson, K. A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 2008, 105, 14265-14270.
[19]
Pedersen, M. B.; Zhou, X. F.; Larsen, E. K. U.; Sørensen, U. S.; Kjems, J.; Nygaard, J. V.; Nyengaard, J. R.; Meyer, R. L.; Boesen, T.; Vorup-Jensen, T. Curvature of synthetic and natural surfaces is an important target feature in classical pathway complement activation. J. Immunol. 2010, 184, 1931-1945.
[20]
Hulander, M.; Lundgren, A.; Berglin, M.; Ohrlander, M.; Lausmaa, J.; Elwing, H. Immune complement activation is attenuated by surface nanotopography. Int. J. Nanomedicine 2011, 6, 2653-2666.
[21]
Westas Janco, E.; Hulander, M.; Andersson, M. Curvature-dependent effects of nanotopography on classical immune complement activation. Acta Biomaterialia 2018, 74, 112-120.
[22]
Zeuthen, C. M.; Shahrokhtash, A.; Sutherland, D. S. Nanoparticle adsorption on antifouling polymer brushes. Langmuir 2019, 35, 14879-14889.
[23]
Vogt, B. D.; Lin, E. K.; Wu, W. I.; White, C. C. Effect of film thickness on the validity of the sauerbrey equation for hydrated polyelectrolyte films. J. Phys. Chem. B 2004, 108, 12685-12690.
[24]
Konradi, R.; Textor, M.; Reimhult, E. Using complementary acoustic and optical techniques for quantitative monitoring of biomolecular adsorption at interfaces. Biosensors 2012, 2, 341-376.
[25]
Voinova, M. V; Rodahl, M.; Jonson, M.; Kasemo, B. Viscoelastic acoustic response of layered polymer films at fluid-solid interfaces: Continuum mechanics approach. Phys. Scr. 1999, 59, 391-396.
[26]
Ouberai, M. M.; Xu, K. R.; Welland, M. E. Effect of the interplay between protein and surface on the properties of adsorbed protein layers. Biomaterials 2014, 35, 6157-6163.
[27]
Reviakine, I.; Johannsmann, D.; Richter, R. P. Hearing what you cannot see and visualizing what you hear: Interpreting quartz crystal microbalance data from solvated interfaces. Anal. Chem. 2011, 83, 8838-8848.
[28]
Reimhult, E.; Larsson, C.; Kasemo, B.; Höök, F. Simultaneous surface plasmon resonance and quartz crystal microbalance with dissipation monitoring measurements of biomolecular adsorption events involving structural transformations and variations in coupled water. Anal. Chem. 2004, 76, 7211-7220.
[29]
Malmström, J.; Agheli, H.; Kingshott, P.; Sutherland, D. S. Viscoelastic modeling of highly hydrated laminin layers at homogeneous and nanostructured surfaces: Quantification of protein layer properties using QCM-D and SPR. Langmuir 2007, 23, 9760-9768.
[30]
Aisen, P.; Listowsky, I. Iron transport and storage proteins. Annu. Rev. Biochem. 1980, 49, 357-393.
[31]
Adamczyk, Z.; Siwek, B.; Zembala, M.; Belouschek, P. Kinetics of localized adsorption of colloid particles. Adv. Colloid Interface Sci. 1994, 48, 151-280.
[32]
Tan, Y. H.; Liu, M. Z.; Nolting, B.; Go, J. G.; Gervay-Hague, J.; Liu, G. Y. A nanoengineering approach for investigation and regulation of protein immobilization. ACS Nano 2008, 2, 2374-2384.
[33]
Strang, C. J.; Siegel, R. C.; Phillips, M. L.; Poon, P. H.; Schumaker, V. N. Ultrastructure of the first component of human complement: Electron microscopy of the crosslinked complex. Proc. Natl. Acad. Sci. USA 1982, 79, 586-590.
[34]
Mortensen, S. A.; Sander, B.; Jensen, R. K.; Pedersen, J. S.; Golas, M. M.; Jensenius, J. C.; Hansen, A. G.; Thiel, S.; Andersen, G. R. Structure and activation of C1, the complex initiating the classical pathway of the complement cascade. Proc. Natl. Acad. Sci. USA 2017, 114, 986-991.
[35]
Larsson, C.; Rodahl, M.; Höök, F. Characterization of DNA Immobilization and subsequent hybridization on a 2D arrangement of streptavidin on a biotin-modified lipid bilayer supported on SiO2. Anal. Chem. 2003, 75, 5080-5087.
[36]
Saptarshi, S. R.; Duschl, A.; Lopata, A. L. Interaction of nanoparticles with proteins: Relation to bio-reactivity of the nanoparticle. J. Nanobiotechnology 2013, 11, 26.
[37]
Tenner, A. J.; Lesavre, P. H.; Cooper, N. R. Purification and radiolabeling of human C1q. J. Immunol. 1981, 127, 648-653.